Publications by authors named "Carolin Guenzel"

Claim this Profile
A
A plain language summary of POLARIS: a study to look at different doses of encorafenib plus binimetinib for people with BRAF V600-mutant melanoma with brain metastasis.
Alexander M Menzies, Georgina V Long, Amiee Kohn, Hussein Tawbi, Jeffrey Webe, Carolin Guenzel

Future Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A plain language summary of the 7-year update from part 1 of the COLUMBUS study: encorafenib and binimetinib for people with BRAF V600-mutant melanoma.
Dirk Schadendorf, Reinhard Dummer, Keith T Flaherty, Caroline Robert, Ana Arance, Carolin Guenzel

Future Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COLUMBUS 7-year update: A randomized, open-label, phase III trial of encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF V600E/K-mutant melanoma.
Dirk Schadendorf, Reinhard Dummer, Keith T Flaherty, Caroline Robert, Ana Arance, Carolin Guenzel

Eur J Cancer· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
POLARIS: A phase 2 trial of encorafenib plus binimetinib evaluating high-dose and standard-dose regimens in patients with V600-mutant melanoma with brain metastasis.
Alexander M Menzies, Georgina V Long, Amiee Kohn, Hussein Tawbi, Jeffrey Weber, Carolin Guenzel

Neurooncol Adv· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Uracil DNA glycosylase interacts with the p32 subunit of the replication protein A complex to modulate HIV-1 reverse transcription for optimal virus dissemination.
Cecile Herate, Clarisse Vigne, Carolin A Guenzel, Marie Lambele, Marie-Christine Rouyez

Retrovirology· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIV-1 Vpr-a still "enigmatic multitasker".
Carolin A Guenzel, Cécile Hérate, Serge Benichou

Front Microbiol· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-domain antibody-SH3 fusions for efficient neutralization of HIV-1 Nef functions.
Jérôme Bouchet, Cécile Hérate, Carolin A Guenzel, Christel Vérollet, Annika Järviluoma

J Virol· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recruitment of the nuclear form of uracil DNA glycosylase into virus particles participates in the full infectivity of HIV-1.
Carolin A Guenzel, Cécile Hérate, Erwann Le Rouzic, Priscilla Maidou-Peindara, Holly A Sadler

J Virol· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
E17A mutation in HIV-1 Vpr confers resistance to didanosine in association with thymidine analog mutations.
Slim Fourati, Isabelle Malet, Carolin A Guenzel, Cathia Soulie, Priscilla Maidou-Peindara

Antiviral Res· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Nipah virus immune-antagonism strategy revealed by experimental and computational study.
Jeremy Seto, Liang Qiao, Carolin A Guenzel, Sa Xiao, Megan L Shaw

J Virol· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis